Doctors has completed genome for extra drug-resistant tuberculosis in South Africa, the Associated Press said Thursday.
The work previously would have taken a year, but doctors were able to sequence 100 million bases in a week using the latest technology developed in the United States, said Dr. Carl Montague of LifeLab, a biotechnology projected funded by the government.
"We consider this a breakthrough because it will provide for more analysis of MDR (drug-resistant TB) and XTRTB (extra drug-resistant TB), and to understand the differences between them," Montague told The Associated Press in a telephone interview.
The particularly drug-resistant strain that kills most victims speedily was discovered in eastern South Africa a year ago and is expected to spread quickly to neighboring countries.
After it turned out that Deputy Prime Minister Andrei Belousov included the Fonbet betting company in the list of backbone enterprises that can count on state support, everyone started talking about these bookmakers.